Please login to the form below

Not currently logged in
Email:
Password:

diagnostic testing

This page shows the latest diagnostic testing news and features for those working in and with pharma, biotech and healthcare.

Keytruda is first FDA-approved drug for molecular indication

Keytruda is first FDA-approved drug for molecular indication

All told it is estimated that 1 in 25 tumours display a high degree of microsatellite instability, and diagnostic testing for the biomarker is both cheap and readily available.

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Behavioural science in 2030 Behavioural science in 2030

    In this model, diagnostic testing will be employed to select appropriate and optimal therapies based on the context of a patient's genetic content.

  • Digital diagnostic tech improves GP accuracy Digital diagnostic tech improves GP accuracy

    A new study using computer-simulated patients has found that GPs can improve the accuracy of their diagnoses if they are given digital diagnostic advice before they start testing for ailments. ... The study found that reminding GPs of diagnoses to

  • Pharma deals during April 2014 Pharma deals during April 2014

    This enables healthcare workers to perform rapid molecular diagnostic testing in a point of care setting, with minimal training.

  • Pharma deals during September 2012 Pharma deals during September 2012

    Chinese BGI-Shenzhen, which operates genome-sequencing centres in China, is to acquire US company Complete Genomics for $118m to expand in the US market for medical and research DNA testing. ... 8+. Response Genetics / GSK. Equity investment. Molecular

  • Interview with Andrea Rappagliosi, EuropaBio Interview with Andrea Rappagliosi, EuropaBio

    There is a growing debate surrounding the role of diagnostic testing in personalised medicine. ... The use of diagnostic testing has steadily expanded, moving from simple diagnosis into screening, predisposition, prognosis, prevention and therapy

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Perspective on biotech leaders

    as genomics experts, clinical diagnostic professionals and academics. ... The future of clinical diagnostics and liquid biopsy. Big data, privacy and the rise of genomic testing.

  • Flarebio Biotech LLC

    Our main business includes recombinant proteins and antibodies (CusAb), ELISA kits (CUSABIO), raw materials for diagnostic reagents (CUSAg), food safety testing products (WHISERKON).

  • Evolution of the wearable tech revolution

    When you combine it with their other findings that physicians are eager to increase patient interactions and are comfortable putting diagnostic testing of basic biometrics into patients’ hands, the transition of

  • Research and development

    Our main business includes recombinant proteins and antibodies (CusAb), ELISA kits (CUSABIO), raw materials for diagnostic reagents (CUSAg), food safety testing products (WHISERKON). ... ScyTek Laboratories, Inc. a Utah, USA corporation involved in the

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics